The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

After a more than decade-long process to bring the experimental drug elamipretide to market, the treatment’s approval has ...

When the Food and Drug Administration needs outside guidance, it normally turns to a trusted source: a large roster of expert ...

CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its ...

The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...

US regulators sent seemingly mixed messages this month about the outlook for animal-derived, or desiccated, thyroid medicines ...

The FDA’s recent issue of five warning letters to brands illegally marketing whipped, mousse and foam sunscreen products ...

The FDA said in letters to five sunscreen makers that they are not authorized to market sunscreen sold in mousse or whipped form.

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

Sublingual cyclobenzaprine (Tonmya), a nonopioid treatment for adults with fibromyalgia, targets nonrestorative sleep, a root ...

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...

The U.S. Food and Drug Administration (FDA) is proposing an update to a decades-old orange juice rule that could give ...